{
    "eid": "2-s2.0-85089948596",
    "title": "Prevalence and predictors of glomerular filtration rate decline in patients with diabetic kidney disease using RAAS blocking agents",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Albuminuria",
        "Diabetic kidney disease",
        "RAAS blocking agents"
    ],
    "authors": [
        "Chanchana Boonyakrai",
        "Sumitra Chukaew",
        "Wilailuck Tuntayothin"
    ],
    "citedby-count": 0,
    "ref-count": 27,
    "ref-list": [
        "Nephropathy in patients with type 2 diabetes mellitus",
        "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD",
        "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease",
        "Clinical manifestations of kidney disease among us adults with diabetes, 1988-2014",
        "Antihypertensive agents for primary prevention of diabetic nephropathy",
        "Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials",
        "Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes",
        "Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes",
        "The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes",
        "Preventing microalbuminuria in type 2 diabetes",
        "A Meta-analysis of the Association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury",
        "Acute kidney injury in patients on SGLT2 inhibitors: A propensity-matched analysis",
        "Empagliflozin and progression of kidney disease in type 2 diabetes",
        "Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus",
        "Clinical challenges in diagnosis and management of diabetic kidney disease",
        "Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists",
        "Standards of medical care in diabetes-2018",
        "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)",
        "Relation between kidney function, proteinuria, and adverse outcomes",
        "Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis",
        "Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts",
        "Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes",
        "Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)",
        "Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients",
        "Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives",
        "Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60014909",
            "affilname": "Taksin Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}